Literature DB >> 18349237

Dietary unsaturated fatty acids increase plasma glucagon-like peptide-1 and cholecystokinin and may decrease premeal ghrelin in lactating dairy cows.

B J Bradford1, K J Harvatine, M S Allen.   

Abstract

Previous reports have indicated that dietary unsaturated fat can decrease energy intake of lactating dairy cattle. However, the mechanism for this response is unclear. To evaluate the potential role of gut peptides, periprandial concentrations of cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1), and ghrelin were measured. From a replicated 4 x 4 Latin square experiment, 4 cows from a single square were selected for analysis of responses to 3 treatments: a control diet (5.5% total fatty acids, 65% unsaturated), a diet with added saturated fat (SAT, 8.3% fatty acids, 47% unsaturated), and a diet with added unsaturated fat (UNS, 7.8% fatty acids, 63% unsaturated). The SAT treatment increased duodenal flow of saturated fatty acids compared with UNS and control and, despite the fact that ruminal biohydrogenation altered fatty acid profiles of digesta, UNS increased duodenal flow of unsaturated fatty acids compared with SAT and control. Blood samples were collected at 8-min intervals through the first 2 meals of the day and analyzed by commercial radioimmunoassays. The UNS treatment increased plasma CCK concentration relative to SAT and control, and increased plasma GLP-1 concentration compared with control. Furthermore, fat treatments tended to suppress the prandial ghrelin surge that was evident for control. Suppression of feed intake by unsaturated fats is likely mediated in part by increased secretion of CCK and GLP-1, and dietary fat may also inhibit ghrelin release before conditioned meals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349237     DOI: 10.3168/jds.2007-0670

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  7 in total

1.  Prepartum fatty acid supplementation in sheep I. Eicosapentaenoic and docosahexaenoic acid supplementation do not modify ewe and lamb metabolic status and performance through weaning.

Authors:  D N Coleman; K C Rivera-Acevedo; A E Relling
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

2.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

3.  Duodenal infusion of fatty acids differentially affects plasma glucagon-like peptide-1 and ghrelin concentrations in sheep.

Authors:  Rika Fukumori; Yoji Masuda; Ayaka Takeuchi; Rina Yanai; Khurchabiling Atchalalt; Borjigin Sarentonglaga; Kazuko Ogata; Mio Yamaguchi; Asuka Hara; Akane Sato; Toshihisa Sugino; Yoshikazu Nagao
Journal:  J Anim Sci       Date:  2018-05-04       Impact factor: 3.159

4.  Effects of protein source and lipid supplementation on conservation and feed value of total mixed ration silages for finishing beef cattle.

Authors:  Gustavo Lazzari; Amanda C O Poppi; Juliana Machado; Antonio V I Bueno; Ana L M Gomes; Clóves C Jobim; João L P Daniel
Journal:  J Anim Sci       Date:  2021-02-01       Impact factor: 3.159

5.  Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis.

Authors:  Kirsten Schulz; Jana Frahm; Susanne Kersten; Ulrich Meyer; Jürgen Rehage; Marion Piechotta; Maria Meyerholz; Gerhard Breves; Dania Reiche; Helga Sauerwein; Sven Dänicke
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

6.  Effect of calcium salt of long-chain fatty acids and alfalfa supplementation on performance of Holstein bulls.

Authors:  Yang He; Wenjing Niu; Qinghua Qiu; Chuanqi Xia; Taoqi Shao; Haibo Wang; Qianwen Li; Zhantao Yu; Zhibiao Gao; Muhammad Aziz Ur Rahman; Huawei Su; Binghai Cao
Journal:  Oncotarget       Date:  2017-12-09

Review 7.  Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review.

Authors:  Undurti N Das
Journal:  J Adv Res       Date:  2018-01-04       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.